Corpus Intelligence IC Memo — PRESENCE SAINTS MARY & ELIZABETH MED 2026-04-26 06:40 UTC
IC Memo — PRESENCE SAINTS MARY & ELIZABETH MED
Investment Committee Memorandum | IL | 266 beds | Grade C | EBITDA uplift $26.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PRESENCE SAINTS MARY & ELIZABETH MED

CCN 140180 | COOK, IL | 266 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PRESENCE SAINTS MARY & ELIZABETH MED is a 266-bed suburban community hospital in COOK, IL with $364.6M in net patient revenue and a 3.7% operating margin. The hospital serves a payer mix of 18.8% Medicare, 8.2% Medicaid, and 73.0% commercial.

Thesis: Undervalued. Our ML models identify $26.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.7% to 11.1% (+736bps).

Net Revenue HCRIS$364.6M
Current EBITDA COMPUTED$13.5M
Operating Margin COMPUTED3.7%
Occupancy HCRIS66.5%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS24.0%
Distress Probability ML44.6%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
79
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 3.7% places it above the state median. Among 79 size-comparable peers (133-532 beds), the median margin is -8.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (133-532), prioritizing same-state peers. 79 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PRESENCE SAINTS MARY & ELIZABE (Target)IL266$364.6M3.7%
LOYOLA UNIVERSITY MEDICAL CENTIL516$1.40B-9.9%
CENTRAL DUPAGE HOSPITALIL347$1.30B16.4%
CARLE FOUNDATION HOSPITALIL433$1.22B11.8%
ANN & ROBERT H. LURIE CHILDRENIL364$1.17B-12.8%
BOARD OF TRUSTEES OF THE UNIVEIL395$1.14B-12.3%
JOHN H. STROGER JR. HOSP OF COIL429$945.3M-22.4%
SWEDISHAMERICAN HOSPITALIL324$752.0M-2.8%
SPRINGFIELD MEMORIAL HOSPITALIL389$732.9M-14.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $26.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.7M+210bp18mo
Cost to Collect4.5%2.5%$7.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.4M+122bp9mo
Clean Claim Rate88.0%96.0%$233K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.7M
Cost to Collect
$7.3M
Denial Rate Reduction
$7.2M
A/R Days Reduction
$4.4M
Clean Claim Rate
$233K
Total EBITDA Uplift$26.8M
Current EBITDA$13.5M
+ RCM Uplift+$26.8M
Pro Forma EBITDA$40.3M
Current Margin3.7%
Pro Forma Margin11.1%
WC Released (1x)$14.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$20.7M$357.1M17.26x76.8%
Base (11x exit)10.0x11.0x$20.7M$399.5M19.31x80.8%
Bull Case9.0x11.0x$18.6M$494.8M26.57x92.7%
Bull (12x exit)9.0x12.0x$18.6M$545.3M29.28x96.5%
Bear Case11.0x10.0x$22.8M$216.2M9.50x56.9%
Bear (11x exit)11.0x11.0x$22.8M$245.2M10.77x60.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 79 hospitals with 133-532 beds
  • Same-state prioritization (n=80)
  • Comp margins: P25=-18.8% / P50=-8.0% / P75=1.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.